How do I diagnose an insulinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Insulinoma

The diagnosis of insulinoma requires a supervised 48-72 hour fast demonstrating Whipple's triad with inappropriately elevated insulin, C-peptide, and proinsulin levels when blood glucose falls below 55 mg/dL. 1

Clinical Presentation and Initial Evaluation

  • Look for symptoms of hypoglycemia:
    • Neuroglycopenic symptoms: confusion, lethargy, periodic numbness
    • Adrenergic symptoms: sweating, palpitations, anxiety
    • Symptoms typically occur during fasting or exercise

Diagnostic Algorithm

Step 1: Laboratory Testing

  • Measure serum insulin, proinsulin, and C-peptide levels 1
  • Diagnostic criteria during hypoglycemia (blood glucose <55 mg/dL):
    • Insulin level >3 mcIU/mL (usually >6 mcIU/mL)
    • C-peptide concentrations ≥0.6 ng/mL
    • Proinsulin levels ≥5 pmol/L 1

Step 2: Supervised Fast (Gold Standard)

  • Perform a supervised 48-72 hour fast 1
    • 48-hour fast is now considered sufficient and should replace the traditional 72-hour fast 2
    • Monitor blood glucose, insulin, C-peptide, and proinsulin levels
    • Test is terminated when hypoglycemia occurs or at completion of time period
    • Most insulinomas (94.5%) can be detected within 48 hours of fasting 2

Step 3: Imaging for Localization

  • Endoscopic ultrasound (EUS): best initial imaging modality (localizes ~82% of pancreatic NETs) 1
  • Multiphasic CT or MRI: should be performed to rule out metastatic disease 1
  • Consider selective arterial calcium stimulation test (Imamura-Doppman procedure) only when:
    • Other localization tests are equivocal or negative
    • For persistent or recurrent insulinoma 1

Important Diagnostic Considerations

Whipple's Triad

Confirm all three elements:

  1. Symptoms of hypoglycemia
  2. Low blood glucose (<55 mg/dL) when symptoms occur
  3. Relief of symptoms after glucose administration

Alternative Testing Methods

  • For outpatient settings or when prolonged fast is not feasible:
    • 5-hour oral glucose tolerance test (OGTT) with measurement of insulin-to-glucose and C-peptide-to-glucose ratios 3
    • Short fasting test (24-hour) initiated overnight at home and continued in outpatient setting 4
    • Recent research shows 91.7% of insulinomas can be diagnosed within 24 hours of beginning a fast 4

Pitfalls to Avoid

  1. False negatives: Some insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia 5

    • Consider OGTT if clinical suspicion is high despite negative fast
  2. Factitious hypoglycemia: Test urinary sulfonylurea to rule out factitious causes 1

  3. Premature termination of fast: Ensure proper monitoring of subtle neuroglycopenic symptoms

  4. Somatostatin analogs: Avoid administering octreotide or lanreotide before diagnosis as they can profoundly worsen hypoglycemia in patients with insulinoma 1

  5. Insulin-to-glucose ratio: An insulin-to-glucose ratio ≥0.3 reflects inappropriate insulin secretion during hypoglycemia 1

By following this diagnostic approach, insulinoma can be accurately diagnosed, allowing for appropriate surgical management which can cure 90% of these tumors that typically follow an indolent course 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.